NRX Pharmaceuticals- Warrants (24/05/2026) Profit Margin

NRX Pharmaceuticals- Warrants (24/05/2026) (NRXPW) currently reports a profit margin of -1070.26% as of March 2026. That compares with -602750.0% in the prior-year period — up 99.8% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore NRX Pharmaceuticals- Warrants (24/05/2026)'s profit margin history and peer comparisons.

NRX Pharmaceuticals- Warrants (24/05/2026)'s profit margin increased from -602750.0% to -1070.26% — a 99.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NRX Pharmaceuticals- Warrants (24/05/2026)'s profit margin of -1070.26% is lower than the Healthcare sector average of 14.34%. That is roughly 7561.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but NRX Pharmaceuticals- Warrants (24/05/2026)'s current -1070.26% should be judged against Healthcare norms (sector average: 14.34%) and against NRXPW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1070.26%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for NRX Pharmaceuticals- Warrants (24/05/2026), and consider following NRXPW for alerts when major investors trade the stock.